ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR312/006/SRR3122406/SRR3122406.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/004/SRR3122404/SRR3122404.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/008/SRR3122408/SRR3122408.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/007/SRR3122407/SRR3122407.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/000/SRR3122410/SRR3122410.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/009/SRR3122409/SRR3122409.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR312/005/SRR3122405/SRR3122405.fastq.gzprimaryOK2000000GenomicsRollins Collegehttps://www.ebi.ac.uk/ena/browser/view/PRJNA309583Epstein-Barr virus (EBV) controls gene expression to transform human B-cells and maintain viral latency. High-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) identified mRNA targets of 44 EBV and 310 human microRNAs (miRNAs) in Jijoye (Latency III) EBV-transformed B-cells.ENAHITS-CLIP, small temporal RNA, CLIP-seq, micro RNA, EBV., microRNA, CLIP-seq assay, INSDC_feature:ncRNA, stRNA, INSDC_qualifier:miRNAhuman being, human., man0.00.00.00.00.00falseHomo sapiensHITS-CLIP miRNA targetome EBV2022-05-122016-01-28PRJNA309583224732089606